Switching from Wegovy to Zepbound

Let’s talk about switching from Wegovy to Zepbound. Both are once-weekly injections designed to support weight loss, but they work a bit differently at the molecular level. The transition is doable but you need to approach it the right way.

Wegovy is Semaglutide. Zepbound is Tirzepatide

Semaglutide is built to mimic a natural hormone GLP-1 that helps the body know when to stop eating. It slows digestion, curbs appetite and gives satiety a stronger voice. In 2021, the FDA cleared Semaglutide for weight loss with the brand name Wegovy.

Zepbound, approved in 2023, is newer and built differently. It contains Tirzepatide, a drug that mimics not just GLP-1, but also GIP - another hormone tied to blood sugar and appetite. The two hormones work together. That dual action might help some users lose more weight or tolerate it better.

So essentially, we’re talking about switching from a single agonist to a dual agonist, from Semaglutide to Tirzepatide.

Main reasons people consider switching

A common reason for switching is when a high dose of Wegovy no longer delivers the expected weight loss results. Many users find that Zepbound offers stronger appetite suppression and more effective weight loss. Research supports this: people lost an average of 5.9% of their body weight in three months with tirzepatide, compared to 3.6% with semaglutide. After a year, tirzepatide resulted in a 15.3% weight loss, while semaglutide showed 8.3%.

Another reason people switch is due to the intense side effects of Wegovy. This is where things get complicated. While evidence suggests Tirzepatide tends to cause more side effects, individual responses vary. Some users report fewer side effects with Tirzepatide, even though studies don’t always predict personal experiences.

Cost, availability and insurance coverage are also key factors. Some people transition because their insurance no longer covers Wegovy or due to changes in insurance plans that make Zepbound a more affordable option.

What are the equivalent doses of Semaglutide and Tirzepatide?

You’ll find various charts online suggesting rough dose equivalencies between semaglutide and tirzepatide. Here's one example.

However, there is no official conversion chart from pharmaceutical companies or clinical studies, since the two medications work through different mechanisms. The doses are not directly interchangeable. Dosing should always be personalized and guided by a healthcare provider.

Titration Protocols for Switching from Wegovy to Zepbound

Most doctors suggest a washout period of 7 to 10 days after your last semaglutide injection before starting tirzepatide. This helps minimize the risk of overlapping side effects, particularly gastrointestinal issues.

The starting dose of Zepbound depends on your previous Wegovy dosage:

• Semaglutide ≤ 0.5 mg/week: Start tirzepatide at 2.5 mg/week, titrating to 5 mg after 4 weeks.

• Semaglutide ≥ 1 mg/week: Begin tirzepatide at 5 mg/week, escalating to 7.5 mg after 4 weeks if tolerated

From what I’ve read in real user feedback, the approach is usually straightforward: people switch medications on their regular injection day without a waiting period.

Below, I’ll share some user reports to provide a better understanding of how the switch works in real-life scenarios:

Side Effects Comparison

After switching to Zepbound, many users report fewer and less intense gastrointestinal issues, like nausea, vomiting and stomach pain. Some users notice a shift in their bowel habitsfrom constipation on Wegovy to more frequent or looser stools on Zepbound.

Weight loss can continue or even accelerate after the change. On top of that, side effects like fatigue and injection site reactions tend to ease up, making the transition smoother overall

Switching from Wegovy to Zepbound might reignite weight loss progress and offer better tolerability for some. But don’t rush it. Start Zepbound at a low dose and gradually increase it rather than switching abruptly at a high dose.

Individual responses vary, so working together with your doctor will help ensure a safe and effective transition.

If you find this post useful, copy the link and share it with someone else walking the GLP-1 path. Every new reader who joins our email list makes a difference.